The drug is preferably an antineoplastic agent such as doxorubicin.

The active agent may be a therapeutic agent such as a chemotherapeutic agent or an antineoplastic agent or an enzyme.

Antineoplastic agent indicated in the treatment of:

These lipopeptides may be administered alone or in combination with a second antineoplastic agent.

In another embodiment of the invention, the composition is formulated with an antineoplastic agent.

Doxorubicin liposome is an antineoplastic agent (cancer medicine).

This invention relates to camptothecin derivatives and pharmaceutically acceptable salts thereof, its manufacturing method and antineoplastic agent containing it.

The patient may be refractory to prior treatment with an anti-neoplastic agent other than dasatinib.

The CD40 may be used in conjunction with at least one antineoplastic agent and/or CD40 inducer.

In other embodiments, the antineoplastic agent is an antineoplastic taxane.

The method optionally further comprises administering a second agent, which can be a stimulating agent that stimulates production of the peptide agent and/or at least one antineoplastic agent.

The problem addressed by the present invention is that of creating an effective antineoplastic agent on the basis of Bortezomib with extended use properties.

In some forms, the ECM bead further comprises at least one additional bioactive agent disposed thereon, for example, a pharmaceutical such as an antineoplastic agent.

Its use as an anti-inflammatory agent is to relieve inflammation and pain, and also as an antipyretic.

Its use as an antineoplastic agent is to inhibit tumour growth.